- Home
- SF vs RGC Comparison
SF vs RGC Comparison
Compare SF & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SF | RGC |
|---|---|---|
| Founded | 1890 | 2014 |
| Country | United States | Hong Kong |
| Employees | 9000 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 11.5B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SF | RGC |
|---|---|---|
| Price | $76.80 | $29.30 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $90.33 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 100.6K |
| Earning Date | 04-22-2026 | 10-31-2025 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.58 | N/A |
| Revenue Next Year | $8.03 | N/A |
| P/E Ratio | $20.53 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $69.31 | $9.39 |
| 52 Week High | $134.74 | $950.00 |
Technical Indicators
Market Signals| Indicator | SF | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.89 | 52.87 |
| Support Level | $75.78 | $21.81 |
| Resistance Level | $83.82 | $33.50 |
| Average True Range (ATR) | 2.40 | 2.01 |
| MACD | 0.20 | -0.10 |
| Stochastic Oscillator | 12.68 | 39.91 |
Price Performance
Historical ComparisonAbout SF Stifel Financial Corporation
Stifel Financial is a diversified financial-services provider that generates revenue from wealth management, investment banking, and lending. The firm was founded in 1890 as a St. Louis-based full-service brokerage but has been transformed under CEO Ronald Kruszewski through a slew of acquisitions into a globally competitive wealth manager, investment bank, and retail and institutional brokerage. The firm generated $5.5 billion in revenue in 2025, with roughly two-thirds derived from wealth management and one-third derived from investment banking and trading.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.